Antimicrobial Adverse Reaction and Drug-Drug Interactions
A special issue of Pharmacy (ISSN 2226-4787).
Deadline for manuscript submissions: closed (31 October 2023) | Viewed by 5719
Special Issue Editor
Interests: antimicrobial adverse reactions; antimicrobial allergies; antimicrobial stewardship; active learning and innoavtive education
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Adverse Drug Reactions (ADR), including drug-drug interactions, are one of the leading causes of morbidity and mortality in health care. Twenty years ago the Institute of Medicine reported that 98,000 deaths occur annually from medical errors. Of these errors, 7000 deaths occur due to ADRs. Nearly 7% of hospitalized patients have a serious ADR with a fatality rate of 0.32%. This translates to more than 2 million serious ADRs in hospitalized patients, and 106,000 deaths annually. Antimicrobials are some of the most commonly prescribed medications and responsible for 25–40% of ADRs. This special theme issue will contain original research about antimicrobial adverse reactions and drug-drug interactions.
Dr. Meghan Jeffres
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmacy is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antibiotic
- antimicrobial
- antibiotic
- adverse effects
- adverse events
- adverse reactions
- hypersensitivity
- drug-drug interactions
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
